Inflammation, Neurodegenerative Diseases, and Environmental Exposures

Abstract: The etiology of neurodegenerative disorders is multifactorial and consists of an interaction between aging, environmental factors, and genetic predisposition. Neuronal cell loss in specific regions of the central nervous system and the resulting clinical symptoms are used to characterize different neurological syndromes. While the selectivity of neuronal cell death is not clearly understood, it is in part attributed to the physiological role and microenvironment of the impacted cells. In this review, innate immune responses in the central nervous system are described. Chronic upregulation of this pathway, orchestrated mainly by microglial cells, may jeopardize neuronal integrity through the prolonged production of toxic inflammatory mediators. Environmental exposures that further enhance the innate immune response may accelerate microglia‐driven neurodegeneration. Environmental factors that can trigger inflammatory events in the central nervous system are lipopolysaccharide, aluminum, and particulate matter present in air pollution. These factors may enhance existing age‐related inflammation in the central nervous system and thus accelerate neuronal toxicity.

[1]  J. Carson,et al.  Air Pollution and Brain Damage , 2002, Toxicologic pathology.

[2]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[3]  J. Russell,et al.  TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation , 2004, Journal of Neuroimmunology.

[4]  M. Staufenbiel,et al.  Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid. , 2002, Journal of neurochemistry.

[5]  K. Abe,et al.  Neuronal nitric oxide synthase (nNOS) immunoreactivity in the spinal cord of transgenic mice with G93A mutant SOD1 gene , 2002, Acta Neuropathologica.

[6]  G. Deuschl,et al.  Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration , 2003, Journal of Neuroimmunology.

[7]  P. Carvey,et al.  Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. , 2002, Brain research. Developmental brain research.

[8]  Bin Liu,et al.  Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease , 2002, Journal of neurochemistry.

[9]  S. Bondy,et al.  The stabilization of ferrous iron by a toxic β-amyloid fragment and by an aluminum salt , 1999, Brain Research.

[10]  Dong-Kug Choi,et al.  Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.

[11]  C. Martyn,et al.  Migrant studies in multiple sclerosis , 1995, Progress in Neurobiology.

[12]  D. Dorman,et al.  Direct olfactory transport of inhaled manganese ((54)MnCl(2)) to the rat brain: toxicokinetic investigations in a unilateral nasal occlusion model. , 2000, Toxicology and applied pharmacology.

[13]  J. Silver,et al.  β-Amyloid of Alzheimer's Disease Induces Reactive Gliosis That Inhibits Axonal Outgrowth , 1993, Experimental Neurology.

[14]  S. Rivest,et al.  Glucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response , 2003, The Journal of Neuroscience.

[15]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[16]  C. Albanese,et al.  Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism , 1998 .

[17]  H. Ichinose,et al.  Changes in cytokines and neurotrophins in Parkinson's disease. , 2000, Journal of neural transmission. Supplementum.

[18]  S. Paul,et al.  The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation , 1998 .

[19]  W. Brück,et al.  Inflammation and degeneration in multiple sclerosis , 2003, Neurological Sciences.

[20]  E. Granieri,et al.  Multiple sclerosis: infectious hypothesis , 2001, Neurological Sciences.

[21]  S. Rivest.  Molecular insights on the cerebral innate immune system , 2003, Brain, Behavior, and Immunity.

[22]  K. Muramoto,et al.  Aluminum Promotes the Aggregation of Alzheimer′s Amyloid β-Protein in Vitro , 1994 .

[23]  C. Combs,et al.  Amyloid Precursor Protein Mediates Proinflammatory Activation of Monocytic Lineage Cells* , 2004, Journal of Biological Chemistry.

[24]  W. D. Kaehny,et al.  The dialysis encephalopathy syndrome. Possible aluminum intoxication. , 1976, The New England journal of medicine.

[25]  Pamela L. Follett,et al.  The Toll-Like Receptor TLR4 Is Necessary for Lipopolysaccharide-Induced Oligodendrocyte Injury in the CNS , 2002, The Journal of Neuroscience.

[26]  J. Schaack,et al.  Overexpression of human α-synuclein causes dopamine neuron death in primary human mesencephalic culture , 2002, Brain Research.

[27]  P. Corey,et al.  Effect of exposure of miners to aluminium powder , 1990, The Lancet.

[28]  D. Munoz,et al.  Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging , 1998, Neurology.

[29]  P. Mander,et al.  Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration , 2002, Neuroscience.

[30]  J. Schoenen,et al.  Nervous system injury: focus on the inflammatory cytokine ‘granulocyte-macrophage colony stimulating factor’ , 2004, Neuroscience Letters.

[31]  A. Sadovnick,et al.  The role of genetic factors in multiple sclerosis susceptibility , 1994, Journal of Neuroimmunology.

[32]  Y. Agid,et al.  Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.

[33]  Nancy A. Jenkins,et al.  Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  James P. O'Callaghan,et al.  Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse , 2002, Experimental Neurology.

[35]  D. Benson,et al.  Alzheimer's disease and Parkinson's disease , 1988, Neurology.

[36]  N. Shibata,et al.  Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation , 2002, Acta Neuropathologica.

[37]  A. Delacourte,et al.  Glial reaction in the hippocampal formation is highly correlated with aging in human brain , 1997, Neuroscience Letters.

[38]  J. Silver,et al.  Regional Differences in Reactive Gliosis Induced by Substrate-Bound β-Amyloid , 1994, Experimental Neurology.

[39]  P. Dobrzanski,et al.  Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease , 1998, Brain Research.

[40]  M. Frampton,et al.  Systemic and cardiovascular effects of airway injury and inflammation: ultrafine particle exposure in humans. , 2001, Environmental health perspectives.

[41]  R. Ransohoff,et al.  CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer , 2004, Journal of Neuroimmunology.

[42]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[43]  B. Liu,et al.  Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons , 2002, The Journal of Neuroscience.

[44]  C. Janeway,et al.  An ancient system of host defense. , 1998, Current opinion in immunology.

[45]  C. Pozzilli,et al.  The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis , 2004, Journal of Neurology.

[46]  Wei Li,et al.  Phosphorylation sensitizes microtubule-associated protein τ to Al3+-induced aggregation , 1998, Neurochemical Research.

[47]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[48]  M. Staufenbiel,et al.  Expression of human β‐secretase in the mouse brain increases the steady‐state level of β‐amyloid , 2002 .

[49]  S. Bondy,et al.  Potentiation of beta-folding of β-amyloid peptide 25–35 by aluminum salts , 1999, Neuroscience Letters.

[50]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[51]  D. Wilcock,et al.  Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice , 2001, Neurobiology of Aging.

[52]  F C Kafatos,et al.  Phylogenetic perspectives in innate immunity. , 1999, Science.

[53]  Patrick L. McGeer,et al.  Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.

[54]  D. Price,et al.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[56]  W. Robberecht,et al.  Minocycline delays disease onset and mortality in a transgenic model of ALS , 2002, Neuroreport.

[57]  Hiroki Toda,et al.  Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.

[58]  D. Carter,et al.  Ibuprofen: effect on inducible nitric oxide synthase. , 1997, Brain research. Molecular brain research.

[59]  E. Gould,et al.  Neurogenesis in the adult is involved in the formation of trace memories , 2001, Nature.

[60]  R. Burnett,et al.  Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. , 2002, JAMA.

[61]  P. Mantyh,et al.  Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide , 1993, Journal of neurochemistry.

[62]  D. D. McKinley,et al.  Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer’s disease , 2001, Brain Research Bulletin.

[63]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[64]  G. Sobue,et al.  Differential expression of inflammation‐ and apoptosis‐related genes in spinal cords of a mutant SOD1 transgenic mouse 
model of familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.

[65]  Trond Peder Flaten,et al.  Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water , 2001, Brain Research Bulletin.

[66]  D Commenges,et al.  Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. , 2000, American journal of epidemiology.

[67]  S. Sawcer,et al.  Searching for needles in haystacks—the genetics of multiple sclerosis and other common neurological diseases , 2003, Brain Research Bulletin.

[68]  C. Morris,et al.  Effect of aluminium on expression and processing of amyloid precursor protein , 1996, Journal of neuroscience research.

[69]  Z. Henderson,et al.  Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence , 2001, Brain Research Bulletin.

[70]  D. Ranoux,et al.  Central nervous system disease in patients with macrophagic myofasciitis. , 2001, Brain : a journal of neurology.

[71]  J. Rose,et al.  Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion , 2004, Journal of Neuroimmunology.

[72]  S. Rivest,et al.  The Bacterial Endotoxin Lipopolysaccharide has the Ability to Target the Brain in Upregulating Its Membrane CD14 Receptor Within Specific Cellular Populations , 1998, Brain pathology.

[73]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[74]  C. Martyn.  Anti-inflammatory drugs and Alzheimer's disease , 2003, BMJ : British Medical Journal.

[75]  P. Carvey,et al.  Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide , 2002 .

[76]  K. Ishii,et al.  The LPS receptor (CD14) links innate immunity with Alzheimer's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  S. Akira,et al.  TIR domain-containing adaptors define the specificity of TLR signaling. , 2004, Molecular immunology.

[78]  Harald Neumann,et al.  Neuronal injury mediated via stimulation of microglial toll‐like receptor‐9 (TLR9) , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  C. Bergeron,et al.  Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories , 1996, Neurology.

[80]  G. Krissansen,et al.  Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. , 2004, Brain : a journal of neurology.

[81]  S. Rivest,et al.  Toll‐like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram‐negative bacterial cell wall components , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  Christian Kaltschmidt,et al.  Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis , 1994, Journal of Neuroimmunology.

[83]  J. Julien,et al.  Exacerbation of Motor Neuron Disease by Chronic Stimulation of Innate Immunity in a Mouse Model of Amyotrophic Lateral Sclerosis , 2004, The Journal of Neuroscience.

[84]  M. Staufenbiel,et al.  Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice , 2002, The Journal of Neuroscience.

[85]  C. Haass,et al.  Physiology and Pathophysiology of α‐Synuclein: Cell Culture and Transgenic Animal Models Based on a Parkinson's Disease‐associated Protein , 2000, Annals of the New York Academy of Sciences.

[86]  N. Bishop,et al.  Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. , 1997, The New England journal of medicine.

[87]  R. Lewis,et al.  Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. , 2002, Human gene therapy.

[88]  Pamela L. Follett,et al.  Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[89]  R. Ransohoff,et al.  Induction of glial L‐CCR mRNA expression in spinal cord and brain in experimental autoimmune encephalomyelitis , 2004, Glia.

[90]  M. Shoji,et al.  Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis , 2002, Apoptosis.

[91]  J. T. Greenamyre,et al.  Parkinson's--Divergent Causes, Convergent Mechanisms , 2004, Science.

[92]  S. Bondy,et al.  Pro-inflammatory effects of aluminum in human glioblastoma cells , 2002, Brain Research.

[93]  J. Erälinna,et al.  Ambient Air Quality and Occurrence of Multiple Sclerosis Relapse , 2003, Neuroepidemiology.

[94]  W. Streit,et al.  Reactive microgliosis , 1999, Progress in Neurobiology.

[95]  K. Blennow,et al.  Intrathecal inflammation precedes development of Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[96]  J. Trojanowski,et al.  Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[97]  P. Caroni,et al.  Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease , 2002, The Journal of Neuroscience.

[98]  D. Lahiri,et al.  Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain , 2004, Journal of neuroscience research.

[99]  C. Finch,et al.  NSAIDS inhibit the IL-1β-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2 , 1997, Brain Research.

[100]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[101]  A Seaton,et al.  Ambient particle inhalation and the cardiovascular system: potential mechanisms. , 2001, Environmental health perspectives.

[102]  Dai Zhang,et al.  Tumor Necrosis Factor Death Receptor Signaling Cascade Is Required for Amyloid-β Protein-Induced Neuron Death , 2004, The Journal of Neuroscience.

[103]  H. Wiśniewski,et al.  Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. , 1999, Brain research. Molecular brain research.

[104]  R. Ravid,et al.  Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.

[105]  T. Kielian.  Microglia and chemokines in infectious diseases of the nervous system: views and reviews. , 2004, Frontiers in bioscience : a journal and virtual library.

[106]  B. Liu,et al.  Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. , 2003, Environmental health perspectives.